Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
McKinsey
Moodys
AstraZeneca
Colorcon

Last Updated: December 2, 2021

DrugPatentWatch Database Preview

Patent: 5,800,828

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 5,800,828
Title: Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
Abstract:Immunoisolatory vehicles having a core and a surrounding jacket are disclosed, the core having a volume in excess of 1 .mu.l and at least about 10.sup.4 living cells capable of secreting a biologically active product or of providing a biological function to a patient, the cells dispersed in a biocompatible matrix formed of a hydrogel or an extracellular matrix component, and the external jacket being permselective, biocompatible and having a molecular weight cutoff permitting passage of molecules between the patient and the core through said jacket to provide said biological product or function.
Inventor(s): Dionne; Keith E. (Rehoboth, MA), Emerich; Dwaine F. (Providence, RI), Hoffman; Diane (Cambridge, MA), Sanberg; Paul R. (Spring Hill, FL), Christenson; Lisa (New Haven, CT), Hegre; Orion D. (Green Valley, AZ), Scharp; David W. (St. Louis, MO), Lacy; Paul E. (Webster Grove, MO), Aebischer; Patrick (Lutry, CH), Vasconcellos; Alfred V. (Cranston, RI), Lysaght; Michael J. (E. Greenwich, RI), Gentile; Frank T. (Warwich, RI)
Assignee: Brown University Research Foundation (N/A)
Application Number:08/179,151
Patent Claims:see list of patent claims

Details for Patent 5,800,828

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Nps Pharmaceuticals, Inc. NATPARA parathyroid hormone For Injection 125511 2015-01-23 ⤷  Free Forever Trial 2015-09-01
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Express Scripts
Mallinckrodt
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.